Cognex (CGNX) Cash & Equivalents (2009 - 2026)

Cognex (CGNX) has reported Cash & Equivalents for 18 consecutive years, with $302.5 million the latest figure, recorded in Q3 2026.

• For the quarter ending Q3 2026, Cash & Equivalents rose 68.71% year-over-year to $302.5 million; the trailing twelve-month figure through Jul 2026 stood at $302.5 million (up 68.71% YoY), and the FY2025 full-year result was $262.9 million, up 41.29% from the prior year.
• Cash & Equivalents grew to $302.5 million in Q3 2026 per CGNX's latest filing, from $237.3 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $395.5 million in Q4 2023 and bottomed at $138.9 million in Q1 2024.
• Historically, Cash & Equivalents has averaged $211.1 million across 5 years, with a median of $183.7 million in 2022.
• The sharpest annual moves came in 2024 and 2026: Cash & Equivalents plunged 50.17% in 2024, then surged 68.71% in 2026.
• Over 5 years, Cash & Equivalents stood at $181.4 million in 2022, then gained by 11.73% to $202.7 million in 2023, then dropped by 8.17% to $186.1 million in 2024, then jumped by 41.29% to $262.9 million in 2025, then grew by 15.06% to $302.5 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $302.5 million, $237.3 million, and $262.9 million for Q3 2026, Q2 2026, and Q4 2025 respectively.